[Federal Register Volume 89, Number 120 (Friday, June 21, 2024)]
[Notices]
[Pages 52090-52092]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13611]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on April 2, 2024, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Medical Technology Enterprise 
Consortium (``MTEC''), has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
changes in its membership. The notifications were filed for the purpose 
of extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, 10x National Security, Aldie, VA; 4WEB, Inc., Frisco, TX; 
Abram Scientific, Inc., South San Francisco, CA; Admetsys Corp., 
Boston, MA; Advanced RNA Vaccine Technologies, Inc., North Bethesda, 
MD; Aergility Corp., Dunnellon, FL; Airway Shield S.L., Santander 
Cantabria, Spain; AmacaThera, Inc., Toronto, CANADA; Ampel LLC, 
Charlottesville, VA; Anthos Group, Inc., Torrance, CA; Apos US 
Management, Inc., New York, NY; Asynchealth, Pebble Beach, CA; Baebies, 
Inc., Durham, NC; Best Practice Associates LLC dba Tria Federal, 
Arlington, VA; Bio-Change, Ltd., Yokneam, ISRAEL; Black Fur Biomedical, 
Tucson, AZ; Blue Spark Technologies, Inc., Westlake, OH; Board of 
Regents, Nevada System of Higher Education on behalf of the University 
of Nevada, Las Vegas, Las Vegas, NV; Board of the Trustees of the 
Colorado School of Mines, Golden, CO; Cadet NM, Inc., Albuquerque, NM; 
Cambridge Research & Development, Inc., Nashua, NH; Canaery, Alachua, 
FL; Coldplasmatech GmbH, Greifswald, GERMANY; ComeBack Mobility, Inc., 
New York, NY; CoolSpine LLC, Woodbury, CT; Cristae Consulting LLC, 
Moorestown, NJ; Directed Systems, Ltd., Cambridge, UNITED KINGDOM; 
Eluciderm, Inc., San Diego, CA; ExThera Medical Corp., Martinez, CA; 
EyeYon Medical, Ltd., Ness Ziona, ISRAEL; Florida Institute of 
Technology, Melbourne, FL; FluidForm, Inc., Waltham, MA; Gigantor 
Technologies, Inc., Melbourne Beach, FL; Global Virtual Training LLC, 
New York, NY; GoodCap Pharmaceuticals, Toronto, CANADA; Hatch Product 
Development LLC, Waukegan, IL; Henley Ion LLC, New Orleans, LA; Idea 
Meds, Inc., New York, NY; Immense Dynamics, Inc., Bremerton, WA; 
Innovative Health Sciences LLC, Chester, NY; Innovosens AB, Inc., 
Wilmington, DE; Interoperability Institute LLC, Lansing, MI; JustBard 
Technologies LLC, Brunswick, MD; KaloCyte, Inc., Baltimore, MD; LaCire 
LLC, Alexandria, VA; Lankenau Institute for Medical Research, 
Wynnewood, PA; Loma Linda University, Loma Linda, CA; Lucid Reality 
Labs LLC, Miami, FL; LumaFlo, Inc., Detroit, MI; Lundquist Institute 
for Medical Innovation at Harbor-UCLA Medical Center, Torrance, CA; 
Medasense Biometrics, Ltd., Ramat Gan, ISRAEL; MediCarbone, Inc., 
Tuscon, AZ; Mitochon Pharmaceuticals, Inc., Blue Bell, PA; Modular 
Matter, Inc., Abingdon, MD; Moonrise Medical, Inc., Oakville, CANADA; 
Noleus Technologies, Inc., Houston, TX; Nou Systems, Inc., Huntsville, 
AL; Noxy Health Products, Inc., Anaconda, MT; Oak Grove Technologies, 
Raleigh, NC; Obsidian Solutions Group, Fredericksburg, VA; Omniox, 
Inc., San Francisco, CA; Osetomics LLC, Glen Mills, PA; Osteolyse, 
Inc., Soda Springs, CA; Owl Therapeutics, San Antonio,

[[Page 52091]]

TX; PathKeeper Surgical, Ltd., Kfar Saba, ISRAEL; PyrAmes, Inc., 
Cupertino, CA; Qidni Labs, Inc., Buffalo, NY; Rafa Laboratories, Ltd., 
Jerusalem, ISRAEL; ReBlood Rx LLC, San Diego, CA; Regerna Therapeutics, 
Inc., New York, NY; Regulatory Quality Management Information Source, 
Inc., Amesbury, MA; Remedor Biomed Ltd., Nof Hagalil, ISRAEL; Renovera, 
PBC, West Lafayette, IN; Respair, Inc., Pittsburgh, PA; RevBio, Inc., 
Lowell, MA; Rion, Inc., Rochester, MN; Saforax Health, Haifa, ISRAEL; 
SCHOTT North America New Ventures, Duryea, PA; SenseVOC LLC, Littleton, 
CO; Serda B.V., Amsterdam, THE NETHERLANDS; SMSbiotech, Inc., San 
Marcos, CA; Stanford University, Stanford, CA; STEER Tech LLC, 
Annapolis Junction, MD; Synapstim Ltd., Herzliya, ISRAEL; Temple 
University--Of The Commonwealth System of Higher Education, 
Philadelphia, PA; The Hospital for Special Surgery Fund, Inc., New 
York, NY; The Institute for Integrative and Innovative Research at the 
University of Arkansas, Fayetteville, Fayetteville, AK; Tietronix 
Software, Inc., Houston, TX; TYBR Health, Inc., Houston, TX; Unit 
Medical Devices, Ltd., Sderot, ISRAEL; University of Arkansas, Little 
Rock, Little Rock, AR; University of Cincinnati, Cincinnati, OH; 
Valiant Harbor International LLC, Bethesda, MD; Vasomune Therapeutics 
US, Inc., Raleigh, NC; Velico Medical, Inc., Beverly, MA; ViBo Health, 
Inc., Los Angeles, CA; Videra Health, Inc., Orem, UT; Vir 
Biotechnology, San Francisco, CA; ViyaMD, Inc., Marina del Rey, CA; 
Western Michigan University Homer Stryker M.D. School of Medicine, 
Kalamazoo, MI; and XO Armor Technologies, Inc., Auburn, AL have been 
added as parties to this venture.
    Also, 2C4 Technologies, Inc., San Antonio, TX; AbViro LLC, 
Bethesda, MD; Acer Therapeutics, Inc., Newton, MA; Advanced Surgical 
Retractor Systems, Inc., Shavano Park, TX; Allied Technologies and 
Consulting LLC, Frederick, MD; Amend Surgical, Inc., Alachua, FL; 
American Military Families Action Network, Tacoma, WA; American Type 
Culture Collection, Manassas, VA; AMK Technologies of Ohio LLC, Mount 
Vernon, OH; Anchor Therapy Clinic, Sacramento, CA; Applied Research 
Center, Aiken, SC; Arcascope, Inc., Arlington, VA; Aruna Bio, Inc., 
Athens, GA; Asante Bio, Tampa, FL; Atorvia Health Technologies, Inc., 
Ottawa, Ontario, CANADA; Avel eCare LLC, Sioux Falls, SD; Axioforce, 
Inc., St. Louis, MO; Bio1 Systems, Inc., San Carlos, CA; BioAge Labs, 
Inc., Richmond, CA; Biobeat Technologies, Ltd., Petach Tikva, ISRAEL; 
Bionet Sonar, Inc., Burlington, MA; BiotechPharma Corp., Severna Park, 
MD; Board of Trustees of the University of Illinois, Champaign, IL; 
Bodies Done Right, Mayfield Village, OH; California Service Dog 
Academy, Visalia, CA; Capital Factory Properties LLC, Austin, TX; 
Channel Clinical Solutions LLC, Raleigh, NC; Children's Hospital Los 
Angeles, Los Angeles, CA; ClearCoast USA LLC, St. Petersburg, FL; 
Concurrent Technologies Corp., Johnstown, PA; Conseqta Technology, 
Arlington, VA; Continuous Precision Medicine, Research Triangle Park, 
NC; CSP Technologies, Inc., Auburn, AL; CTD Group LLC, Vashon, WA; 
Daxor Corp., Oak Ridge, TN; Decisive Point Group, Beacon, NY; 
DermiSense, Inc., Richmond, VA; DHR Health Institute for Research and 
Development, Edinburg, TX; Dog Tag Buddies, Billings, MT; D-Prime LLC, 
McLean, VA; Drexel University, Philadelphia, PA; Eagle Global 
Scientific LLC, San Antonio, TX; Endoluxe, Inc., Dunwoody, GA; 
Endomedix, Inc., Montclair, NJ; Engineering & Computer Simulations, 
Inc., Orlando, FL; Entasis Therapeutics, Waltham, MA; FireFlare Games 
LLC, Cheyenne, WY; Float Lab Technologies, Inc., Venice, CA; Foothold 
Labs, Inc., Olathe, KS; Gel4Med, Lowell, MA; GelMEDIX, Inc., Newton, 
MA; GelSana Therapeutics, Inc., Aurora, CO; Global Resonance 
Technologies LLC, Shelburne, VT; Grand Valley State University, Grand 
Rapids, MI; Hafion, Inc., Ann Arbor, MI; Hope 4 You Global LLC, Lowell, 
AR; Hubly, Inc. dba Hubly Surgical, Evanston, IL; Human Systems 
Integration, Inc., East Walpole, MA; Icahn School of Medicine at Mount 
Sinai, New York, NY; ICON Government and Public Health Solutions, 
Hinckley, OH; Idion, Inc., Darien, CT; iFyber LLC, Ithaca, NY; Incell 
Corp. LLC, San Antonio, TX; IOTAI, Inc., Fremont, CA; Jana Care, Inc., 
Watertown, MA; JC3 LLC, Rockbridge Baths, VA; Joint Research and 
Development, Inc., Stafford, VA; Jurata Thin Film, Inc., Chapel Hill, 
NC; K9s for Warriors, Ponte Vedra Beach, FL; KBR, Beavercreek, OH; 
Kerecis, Ltd., Isafjordur, ICELAND; Longhorn Vaccines and Diagnostics 
LLC, Bethesda, MD; Lynntech, Inc., College Station, TX; Manzanita 
Pharmaceuticals, Inc., Woodside, CA; Maravai Life Sciences, San Diego, 
CA; MCPC, Cleveland, OH; Mechano Therapeutics LLC, Philadelphia, PA; 
MediView XR, Inc., Cleveland, OH; Medtronic, Minneapolis, MN; MeMed US, 
Inc., Milpitas, CA; Methodist Hospital Research Institute dba Houston 
Methodist Research Institute, Houston, TX; Microbion Corp., Bozeman, 
MT; Milestone Scientific, Inc., Roseland, NJ; MiMedx Group, Inc., 
Marietta, GA; Muscle Activation Techniques, Englewood, CO; MVK 
Pharmaceuticals LLC, Indianapolis, IN; My Buddies Place, Inc., 
Pasadena, CA; Nakamir, Inc., Palo Alto, CA; Neurotrauma Sciences LLC, 
Alpharetta, GA; New York University School of Medicine, New York, NY; 
nFlux, Inc., Palm Springs, CA; NightHawk Biosciences, Inc., 
Morrisville, NC; Nihon Kohden OrangeMed, Inc., Santa Ana, CA; North 
Carolina Biotechnology Center, Research Triangle Park, NC; NovoPedics, 
Inc., Princeton, NJ; Nyrada, Inc., Gordon, AUSTRALIA; Odic, Inc., 
Littleton, MA; Omnicure, Inc., Ladue, MO; Oregon Biomedical Engineering 
Institute, Inc., Wilsonville, OR; OrganaBio LLC, South Miami, FL; 
Orthoforge, Inc., East Grand Rapids, MI; Otter Cove Solutions LLC, 
Gaithersburg, MD; Pacific Institute for Research and Evaluation, 
Beltsville, MD; Padagis US LLC, Allegan, MI; Palantir USG, Inc., Palo 
Alto, CA; PathoGene, Inc., Monrovia, CA; Paxauris LLC, Phoenix, AZ; 
Phagelux, Inc., Montr[eacute]al, CANADA; Philips North America LLC, 
Cambridge, MA; Population Sleep LLC, Dallas, TX; PortaVision Medical 
LLC, Jefferson, LA; ppx-TEC LLC, Jackson, MS; Precision Trauma LLC, 
Columbus, GA; Problem Solutions LLC, Johnstown, PA; Prohuman 
Technologies, Concord, NC; Promethean LifeSciences, Inc., Pittsburgh, 
PA; Purdue University, West Lafayette, IN; Red One Medical Devices LLC, 
Savannah, GA; Regenerative Processing Plant LLC, Tampa, FL; Regranion 
LLC, Mt. Pleasant, SC; Renerva LLC, Pittsburgh, PA; Resilient 
Lifescience, Inc., Pittsburgh, PA; Reveille Group, Tampa, FL; Rock West 
Composites, Inc., San Diego, CA; RST-Sanexas, Las Vegas, NV; SafeBeat 
Rx, Inc., Chico, CA; SafeBVM Corp., Boston, MA; Safeguard Surgical, 
Tampa, FL; Safi Biotherapeutics, Inc., Cambridge, MA; Saint Barnabas 
Medical Center, Livingston, NJ; Saint Louis University, St. Louis, MO; 
Sanofi Pasteur, Swiftwater, PA; Scientific & Biomedical Microsystems 
LLC, Glen Burnie, MD; SeaStar Medical, Inc., Denver, CO; Securisyn 
Medical LLC, Highlands Ranch, CO; Senseye, Inc., Austin, TX; Shee 
Atik[aacute] Enterprises, Huntsville, AL; Sherpa 6, Inc., Littleton, 
CO; Shipcom Federal Solutions LLC, Belcamp, MD; SLSCO, Ltd., Galveston, 
TX; Softox Solutions AS, Fornebu, Norway; Soliyarn, Belmont, MA; Sophic 
Synergistics LLC, Houston, TX; Sparta Biomedical, Inc., Chatham, NJ; 
SPEAR Human Performance, Inc., Sandy

[[Page 52092]]

Springs, GA; SpineThera, Inc., Plymouth, MN; Steadman Philippon 
Research Institute, Vail, CO; Stellarray, Inc., Austin, TX; Sterogene 
Bioseparations, Inc., Carlsbad, CA; TechEn, Inc., Milford, MA; Terasaki 
Institute for Biomedical Innovation, Los Angeles, CA; Texas A&M 
University, College Station, TX; Texas Research & Technology 
Foundation, San Antonio, TX; The Emmes Company LLC, Rockville, MD; The 
Research Institute of the McGill University Health Centre, Montreal, 
CANADA; TiER1 Performance Solutions, Covington, KY; Transom Scopes, 
Inc. dba Instrument Technology, Inc., Westfield, MA; Trustees of the 
University of Pennsylvania, Philadelphia, PA; UCHU Biosensors, Inc., 
Newark, NJ; University of Miami, Coral Gables, FL; University of 
Southern California, Los Angeles, CA; U-Smell-It LLC, Guilford, CT; 
Vaxxas, Cambridge, MA; Viele Exploratory Sustainable Solutions LLC, 
Livingston Manor, NY; Virion Therapeutics LLC, Newark, DE; Weinberg 
Medical Physics, Inc., North Bethesda, MD; Westat, Inc., Rockville, MD; 
Xheme, Inc., Newton, MA; Xomix, Ltd., Chicago, IL; and ZeSa LLC, Eden 
Prarie, MN have withdrawn as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MTEC intends to file additional 
written notifications disclosing all changes in membership.
    On May 9, 2014, MTEC filed its original notification pursuant to 
section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to section 6(b) of the Act on June 9, 
2014 (79 FR 32999).
    The last notification was filed with the Department on January 9, 
2024. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on February 6, 2024 (89 FR 8246).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-13611 Filed 6-20-24; 8:45 am]
BILLING CODE P